Prosper Okonkwo

Rifabutin pharmacokinetics and safety among TB/HIV-coinfected children receiving lopinavir/ritonavir-containing second-line ART.

Rawizza HE, Oladokun R, Ejeliogu E, Oguche S, Ogunbosi BO, Agbaji O, Odaibo G, Imade G, Olaleye D, Wiesner L, Darin KM, Okonkwo P, Kanki PJ, Scarsi KK, McIlleron HM.

J Antimicrob Chemother. 2021 02 11. 76(3):710-717. PMID: 33294914

Cohort profile: the Nigerian HIV geriatric cohort study.

Dakum P, Avong YK, Odutola MK, Okuma J, Kayode GA, Nta IE, Ndembi N, Mensah C, Khamofu H, Okonkwo P, Okpanachi JO, Ezeanolue E.

BMC Public Health. 2020 Nov 26. 20(1):1797. PMID: 33243227

Multilevel modelling and multiple group analysis of disparities in continuity of care and viral suppression among adolescents and youths living with HIV in Nigeria.

Badejo O, Noestlinger C, Jolayemi T, Adeola J, Okonkwo P, Van Belle S, Wouters E, Laga M.

BMJ Glob Health. 2020 11. 5(11). PMID: 33154102

The impact of user fees on uptake of HIV services and adherence to HIV treatment: Findings from a large HIV program in Nigeria.

Ahonkhai AA, Regan S, Idigbe I, Adeniyi O, Aliyu MH, Okonkwo P, Adeola J, Losina E, Musa Z, Ezechi O, Freedberg KA.

PLoS One. 2020. 15(10):e0238720. PMID: 33031440

Opportunities and challenges to integrating mental health into HIV programs in a low- and middle-income country: insights from the Nigeria implementation science Alliance.

Ezeanolue EE, Iheanacho T, Adedeji IA, Itanyi IU, Olakunde B, Patel D, Dakum P, Okonkwo P, Akinmurele T, Obiefune M, Khamofu H, Oyeledun B, Aina M, Eyo A, Oleribe O, Oko J, Olutola A, Gobir I, Aliyu MH, Aliyu G, Woelk G, Aarons G, Siberry G, Sturke R.

BMC Health Serv Res. 2020 Sep 29. 20(1):904. PMID: 32993621

The impact of HIV-1 subtypes on virologic and immunologic treatment outcomes at the Lagos University Teaching Hospital: A longitudinal evaluation.

Ogbenna AA, Meloni S, Inzaule S, Hamers RL, Sigaloff K, Osibogun A, Adeyemo TA, Okonkwo P, Samuels JO, Kanki PJ, Rinke de Wit TF, Akanmu AS.

PLoS One. 2020. 15(8):e0238027. PMID: 32841264

Longitudinal evaluation of adherence, retention, and transition patterns of adolescents living with HIV in Nigeria.

Meloni ST, Agaba P, Chang CA, Yiltok E, Oguche S, Ejeliogu E, Agbaji O, Okonkwo P, Kanki PJ.

PLoS One. 2020. 15(7):e0236801. PMID: 32735566

A preprogram appraisal of factors influencing research productivity among faculty at college of medicine, University of Lagos.

Ogunsola FT, Odukoya OO, Banigbe B, Caleb-Adepoju SO, Folarin O, Afolabi BB, Okubadejo NU, Adeyemo WL, Akanmu AS, Osuntoki A, Okonkwo P, Murphy R, Kanki P.

Ann Afr Med. 2020 Apr-Jun. 19(2):124-130. PMID: 32499469

Epidemiologic and viral predictors of antiretroviral drug resistance among persons living with HIV in a large treatment program in Nigeria.

Ekong E, Ndembi N, Okonkwo P, Dakum P, Idoko J, Banigbe B, Okuma J, Agaba P, Blattner W, Adebamowo C, Charurat M.

AIDS Res Ther. 2020 02 17. 17(1):7. PMID: 32066473

Low levels of HIV-1 drug resistance mutations in patients who achieved viral re-suppression without regimen switch: a retrospective study.

Onwuamah CK, Okpokwu J, Audu R, Imade G, Meloni ST, Okwuraiwe A, Chebu P, Musa AZ, Chaplin B, Dalhatu I, Agbaji O, Samuels J, Ezechi O, Ahmed M, Odaibo G, Olaleye DO, Okonkwo P, Salako BL, Raizes E, Yang C, Kanki PJ, Idigbe EO.

BMC Microbiol. 2020 01 20. 20(1):17. PMID: 31959116